Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vicki Morrison
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Cadillac
Los Angeles, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Kaiser Permanente-San Diego Mission
San Diego, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Graham Hospital Association
Canton, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Eureka Hospital
Eureka, Illinois, United States
- Galesburg Cottage Hospital
Galesburg, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Western Illinois Cancer Treatment Center
Galesburg, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Hopedale Medical Complex - Hospital
Hopedale, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Community Cancer Center Foundation
Normal, Illinois, United States
- Illinois Cancercare-Ottawa Clinic
Ottawa, Illinois, United States
- Ottawa Regional Hospital and Healthcare Center
Ottawa, Illinois, United States
- Osf Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
Pekin, Illinois, United States
- Pekin Hospital
Pekin, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Proctor Hospital
Peoria, Illinois, United States
- Illinois Valley Hospital
Peru, Illinois, United States
- Valley Radiation Oncology
Peru, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2007
- Primary completion
- 31 Dec 2012
- Completion
- 21 Jan 2014
- Last update posted
- 30 Oct 2018
- Registered enrollment
- 53
- Registry id
- NCT00553644
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.